About Enzyme
Enzyme is a Technology company based in San Francisco (United States) founded in 2016 by Jared Seehafer and Jacob Graham, and was acquired by Greenlight Guru in July 2025. Cloud-based QMS for FDA compliance in medical devices is provided. It operates in the Technology and Healthcare sectors. Enzyme has raised $1.97 million across 2 funding rounds from investors including Greenlight Guru, Refactor Capital and DCVC. The company has 19 employees. Its chief executive, as recorded, is Jared Seehafer. Enzyme offers products and services including Enzyme QMS, Document Control, Change Control, and Risk Management. Its focus areas include Enterprise Applications, GRC Software, Compliance and Industry. Its legal entity is ENZYME CORPORATION. Its competitors include MasterControl, Dot Compliance and Greenlight Guru; 3 of its 3 listed competitors have raised funding.
Company details
Enzyme was founded in 2016 in San Francisco, United States, and operates in the healthcare technology sector. A cloud-based quality management system is offered to medical device and diagnostic companies for managing FDA compliance workflows. Compliance and quality systems are delivered as a service through a web application, supporting operations in gaining and maintaining regulatory adherence.
- Headquarters San Francisco, United States
- Employees 19
- Founders Jared Seehafer, Jacob Graham
- Stage Acquired
- SectorsTechnologyHealthcare
- Email••••••••
- Website enzyme.com
- Social LinkedIn X
- Acquired by Greenlight Guru (Jul 2025)
- Legal Name Enzyme Corporation
- Total Equity Funding$1.97M (USD)
in 2 rounds
- Latest Funding Round$1.85M (USD), Seed
Jan 2018
- InvestorsGreenlight Guru
& 6 more
- Employee Count19
- Acquired byGreenlight Guru
(Jul 2025)
Products & Services of Enzyme
Enzyme offers a comprehensive portfolio of products and services, including Enzyme QMS, Document Control, Change Control, and Risk Management.
Platform for document control and compliance in life sciences.
Tool for managing and tracking regulatory documents.
System for overseeing changes in quality processes.
Software for identifying and mitigating risks in products.
Funding Insights of Enzyme
Enzyme has successfully raised a total of $1.97M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.85 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.97M
- Total Rounds 2
- Last Round Seed — $1.85M
- First Round $120,000
(Jun 2017)
- Investors Count 6
All 2 funding rounds of Enzyme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $1.85M | Seed | – | Refactor Capital | |
| Jun 2017 | $120,000 | Seed | – | Y Combinator | – |
7 investors in total: 6 institutional and 1 angel.
Investors in Enzyme
Enzyme has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Greenlight Guru, Refactor Capital and DCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed and early-stage investments are made across US and India. | refactor.com | Burlingame, United States | ||
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
Digital Health focused VC & Accelerator firm investing in the US | rockhealth.com | San Francisco, United States | ||
Early-stage investments are provided by Soma Capital to startups. | somacap.com | San Francisco, United States | ||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
EI Elizabeth Iorns | Founder of Science Exchange, angel investor, biotech innovator | unknown_1e8e78629a9941c09 | ||
Cloud-based quality management software is offered for medical device manufacturers. | 2013 | greenlight.guru | Indianapolis, United States |
Investor details for Enzyme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enzyme
6 people are tracked at Enzyme (3 in leadership, 3 in team); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Jared Seehafer | Co-Founder & CEO | Leadership |
Jacob Graham | Co-Founder | Leadership |
Bruno Barros | Director of Design | Leadership |
Rowena Bozcaada | Software Test Engineer II | Team |
Ali Edgar | Controller | Team |
Samuel Haro | Software Quality Engineer | Team |
Complete people profiles for Enzyme
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enzyme
4 dated milestones of Enzyme across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Enzyme is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Seed, of $1.9M.
- Exit Acquired by Greenlight Guru.
Competitors of Enzyme
Enzyme has 3 listed competitors in our database, 3 of them funded. They include MasterControl, Dot Compliance and Greenlight Guru.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mastercontrol.com | 1994 | Salt Lake, United States | $150M | 560 | Provider of governance, risk and compliance solutions for life sciences industries | |
| dotcompliance.com | 2016 | Phoenix, United States | $40.5M | Cloud based quality management software | ||
| greenlight.guru | 2013 | Indianapolis, United States | $121.25M | 154 | Cloud-based quality management software is offered for medical device manufacturers. |
Detailed competitors of Enzyme
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Enzyme
The website of Enzyme (enzyme.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 8.1% vs previous month
Top companies in GRC, Risk & Compliance Software
3 companies that operate in the same segment as Enzyme (GRC, Risk & Compliance Software) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Platform that provides data analysis and management solutions | 2003 | Denver, Colorado, United States | USD 2.46 B | USD 2.87 B | 5,915 | |
Cybersecurity and zero trust solutions are delivered for secure networks. | 2007 | San Jose, California, United States | USD 148 M | USD 3.35 B | 9,616 | |
Identity and access management solutions are provided for developers. | 2013 | Bellevue, Washington, United States | USD 332.75 M | 350 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enzyme
Enzyme was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Enzyme is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jared Seehafer is the CEO of Enzyme, as recorded in our data. They have also founded this company.
Enzyme is a funded company, having raised a total of $1.97M across 2 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Jun 2017.
Enzyme has 19 employees.
Enzyme was founded in 2016 in San Francisco, United States, and operates in the healthcare technology sector. A cloud-based quality management system is offered to medical device and diagnostic companies for managing FDA compliance workflows. Compliance and quality systems are delivered as a service through a web application, supporting operations in gaining and maintaining regulatory adherence.
Enzyme's top competitors include MasterControl, Greenlight Guru and Dot Compliance.
Enzyme offers Enzyme QMS, Document Control, Change Control, and Risk Management.
Enzyme has 7 investors. Key investors include Greenlight Guru, Refactor Capital, DCVC, Rock Health, and Elizabeth Iorns.
Enzyme operates through Enzyme Corporation.
Yes. Enzyme was acquired by Greenlight Guru in July 2025.